March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete ...

The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...

Weight-loss patients may soon have access to more GLP-1 treatments as Eli Lilly confirmed the local regulator was evaluating its new oral obesity drug, orforglipron, which a recent study showed was ...

March 4 () - PepGen said on Wednesday that the U. Food and Drug Administration has placed ‌a partial clinical hold on its mid‑stage trial of ‌a rare muscle disease drug, sending its shares plunging ...

The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients and compounding pharmacies over concerns about access and ...

The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who ...

The FDA has outlined a proposed approval pathway for customized drugs and gene-editing therapies designed for rare and ...

Over 100 chemicals of unknown safety were secretly added to foods and supplements without notifying the public or the FDA, a ...

Increased demand for estrogen patches, particularly twice weekly doses, are in short supply nationally, causing delays for patients in Greater Boston.

A new Environmental Working Group report says companies used a regulatory loophole known as “generally recognized as safe” to introduce ingredients into food products without notifying the FDA.